Adenoscan

See also: Generic Adenocard

Adenoscan is a brand name of adenosine, approved by the FDA in the following formulation(s):

ADENOSCAN (adenosine - injectable; injection)

• 
  Manufacturer: ASTELLAS
  
  Approval date: May 18, 1995
  
  Strength(s): 3MG/ML ^[RLD]

Has a generic version of Adenoscan been approved?

No. There is currently no therapeutically equivalent version of Adenoscan available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Adenoscan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Selective vasodilation by continuous adenosine infusion
  Patent 5,731,296
  Issued: March 24, 1998
  Inventor(s): Sollevi; Alf
  Assignee(s): Item Development AB
  This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.
  
  Patent expiration dates:
  
  
  • March 24, 2015
    
    ✓ 
    Patent use: SELECTIVE VASODILATION BY CONTINUOUS ADENOSINE INFUSION
  
  

See also...

• Adenosine Consumer Information (Wolters Kluwer)
• Adenosine AHFS DI Monographs (ASHP)